Precision
Bio-Science

A personalized approach to activate and regulate your immune system to defeat disease

Become An Investor

What We Do

Provide physicians and patients with personalized precision-based therapies designed to give hopeful advances in health to better their lives.

Physicians & Institutions

It’s not about discovering a new drug for the disease, it's about creating the unique solution for the patient.

Find Out More

Patients

Neo7Logix Five Step Personalized Immune Therapy Personalized Immunotherapy is a simple process that individualizes your treatment to program your immune system to fight and regulate against disease. This is achieved in five steps.

Find Out More

Research and Development

Provide physicians and patients with personalized precision-based therapies designed to give hopeful advances in health to better their lives.

PBIMA - PES

Neo7logix PES (Personalized Edited Sequence) is registered as a provisional patent with the USPTO as an integral part of PBIMA (Precision-Based Immunomolecular Augmentation). Neo7logix’s unification API is also known as NEO7UAPI.

Neo7Logix’s precision profiling platform to select final pooled sequence immune editing design of the patient matching sequences specific to the patient’s disease but more importantly, unique to that patients’ immune defense and regulatory requirements. The focal strength of PES is the activation of natural cell and humoral defense and regulation using the patient’s prime edited sequences to initiate sustained immunity against disease.

Covid 19

SOLVx-COVID-19

Neo7logix is a real time surveillance in real time technology producing a design within 24-48 hours as a multi- mechanism design, which included replication proteins, molecular transcription signals and receptors and both humoral and cellular adaptive immune responses that included the loss of T Cell responses that are neutralized by the virus as observed by the COVID-19 research community.

Neo7logix SOLVx-Disease-X is based upon the similar platform design as SOLVx-COVID-19. The difference is we focus upon other threatening fast replicating novel viruses that could fast become a pandemic threat to the world population. We have focused on the top viral list produced by WHO, CDC and authoritative agencies.

Please contact if interested in discussing further: info@neo7logix.com

Contact Us

<
Loading
Your message has been sent. Thank you!